-+ 0.00%
-+ 0.00%
-+ 0.00%

Entera Bio Q2 EPS $(0.06) Misses $1.21 Estimate

Benzinga·08/08/2025 20:10:04
Listen to the news
Entera Bio (NASDAQ:ENTX) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $1.21 by 104.96 percent. This is unchanged from the same period last year.